<SEC-DOCUMENT>0001683168-20-000837.txt : 20200316
<SEC-HEADER>0001683168-20-000837.hdr.sgml : 20200316
<ACCEPTANCE-DATETIME>20200316165535
ACCESSION NUMBER:		0001683168-20-000837
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200313
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200316
DATE AS OF CHANGE:		20200316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		20717909

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 3pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><FONT STYLE="font-size: 8pt"></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 24%; color: #ACA899">

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>FORM 8-K</B></FONT></P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 24%; color: #ACA899">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported
March 13, 2020)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 26%; color: #ACA899">

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>RADNET,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<HR SIZE="1" NOSHADE ALIGN="CENTER" STYLE="width: 93%; color: #ACA899">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; text-align: center">Delaware</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center">001-33307</TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center">13-3326724</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction of Incorporation)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(IRS Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">1510 Cotner
Avenue<BR>
Los Angeles, California 90025<BR>
<FONT STYLE="font-size: 10pt">(Address of Principal Executive Offices) (Zip Code)</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(310)&nbsp;445-2800<BR>
<FONT STYLE="font-size: 10pt">(Registrant&rsquo;s Telephone Number, Including Area Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section
12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 33%"><FONT STYLE="font-size: 10pt"><U>Title of Each Class</U></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 34%"><FONT STYLE="font-size: 10pt"><U>Trading Symbol(s)</U></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 33%"><FONT STYLE="font-size: 10pt"><U>Name of each exchange on which registered</U></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">Common Stock, $.0001 par value</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">RDNT</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">NASDAQ Global Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[&nbsp;&nbsp;] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[&nbsp;&nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b) )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c) )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 3pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 8.01</B></TD><TD STYLE="text-align: justify"><B>OTHER EVENTS. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 13, 2020 RadNet, Inc.
(&ldquo;RadNet&rdquo;) held a noticed public conference call regarding the recent agreement to acquire DeepHealth, Inc. by RadNet
and RadNet&rsquo;s plans for the use of artificial intelligence. Howard G. Berger, M.D., President &amp; CEO of RadNet, and Dr.
Gregory Sorensen, Chief Executive Officer and Co-Founder, DeepHealth Inc., hosted the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in Item 8.01
of this Current Report, included in Exhibit 99.1 is being furnished and shall not be deemed &ldquo;filed&rdquo; for purposes of
Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in
Item 8.01 of this Current Report, including Exhibit 99.1 shall not be incorporated by reference into any registration statement
or other document filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD STYLE="text-align: justify"><B>FINANCIAL STATEMENTS AND EXHIBITS. </B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 30%"><U>Exhibit Number</U></TD>
    <TD STYLE="width: 70%"><U>Description of Exhibit</U></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>99.1</TD>
    <TD><A HREF="radnet_8k-ex9901.htm">Transcript of conference call.</A></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 29%">Date:&nbsp;&nbsp;March 16, 2020</TD>
    <TD STYLE="width: 71%; padding-left: 0.3in; text-indent: 1.2in"><B>RADNET, INC.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">By: <U>/s/ Mark D. Stolper&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Name: Mark D. Stolper<BR>
        Title: Chief Financial Officer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_8k-ex9901.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Blue"><B>C O R P O
R A T E &nbsp;&nbsp;&nbsp;P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, </B><I>President
and Chief Executive Officer, RadNet Inc.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_Hlk35247838"></A><B>Dr. Gregory
Sorensen, </B><I>Chief Executive Officer and Co-Founder, DeepHealth Inc.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Blue"><B>C O N F E
R E N C E &nbsp;&nbsp;&nbsp;C A L L &nbsp;&nbsp;&nbsp;P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp;
Company, LLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Blue"><B>P R E S E
N T A T I O N</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day everyone. Welcome to the RadNet
Inc. DeepHealth Artificial Intelligence Call. Today&rsquo;s conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I would like to turn the
conference over to Dr. Howard Berger, President and Chief Executive Officer of RadNet Inc. Please go ahead, sir.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Operator. Good morning everyone.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This is Dr. Howard Berger calling in. Two
days ago RadNet announced that it had acquired DeepHealth and formed a division for artificial intelligence that will be led by
the president of DeepHealth, Dr. Greg Sorensen. Today, we want to talk about RadNet&rsquo;s decision to move more substantively
into artificial intelligence as well as the strategy that hopefully RadNet and DeepHealth will be executing together to accomplish
those goals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ten years ago RadNet made a critical decision
to invest and own its own information technology platform, which we call eRAD, which would serve as the backbone for managing a
widely distributed network of imaging centers. The premise of this decision was based on both economic and operating requirements,
(inaudible) representing an existential necessity. Indeed, the strategy has proven successful as operating RadNet without this
capability seems improbable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I believe RadNet, and in fact all of radiology
and imaging is at a similar crossroads. Artificial intelligence will undoubtedly impact every facet on how the practice of imaging
is delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given the size to which RadNet has grown,
and likely to continue growing, artificial intelligence becomes another existential necessity to maximize operational and clinical
opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,255,255); border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: justify">RadNet, Inc. &ndash; Deep Health Artificial
Intelligence Call, March 13, 2020</P>


</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Over the past year RadNet and DeepHealth
have been corroborating in the use of artificial intelligence for mammography. During this period we came to know the DeepHealth
team, and in particular, Dr. Gregory Sorensen. When RadNet made the decision to make a substantial investment into artificial intelligence,
it was obvious that Dr. Sorensen&rsquo;s credentials were uniquely qualified to lead this effort. Clinical and research radiologist,
business and technology experience, running the North American division of Siemens Healthcare, and evolving the DeepHealth effort
in mammography AI over the past four years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opportunities which lie ahead in artificial
intelligence practically fall into three categories: one, clinical accuracy and productivity enhancement; two, business and operating
efficiencies; and three, revenue enhancement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before I turn the call over to Dr. Sorensen,
I would like to give some perspective to the category of revenue enhancement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Procedures performed in diagnostic imaging
centers generally require a prescription for the particular exam from the reporting physician. In addition, for advanced imaging
procedures, authorization is also required before the exam can be performed. The only exception to this rule is screening mammography,
which the patient can self-refer for annual or bi-annual follow-up. As a result of this capability, RadNet has sought tools to
improve compliance and increase volume by direct outreach to the patient population. Since RadNet implemented the White Rabbit
AI application, mammography volume in most of our regions has increased substantially. The benefit of using mammography and artificial
intelligence for more accurate and earlier diagnosis of breast cancer is rapidly being validated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through the recent technology advances,
the opportunity to use AI for prostate, lung and colon cancer screening are now possible. Similar to mammography, the potentially
new screening tools should eventually be adopted by patients and payors as both affordable and necessary, and as a part of population
health initiatives which improve outcomes and reduce costs. Thus, the use of AI for these new screening tools should create a significant
benefit which will help direct patients to centers which utilize this capability. Both RadNet and DeepHealth share this vision
and made the combination and collaboration opportunities compelling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d like to turn the call over now
to Dr. Gregory Sorensen who will further elaborate on both the circumstances which led RadNet and DeepHealth to come together,
as well as his vision of the opportunities for the future in artificial intelligence. Greg?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Gregory Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard. Hello everyone. It&rsquo;s
a pleasure to be with you on the call today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d like to begin by affirming what
Dr. Berger has said about the <A NAME="a_Hlk35247931"></A>potential impact for artificial intelligence, and in particular a form
of machine learning known as deep learning, to improve the health of women and men.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger&rsquo;s categorization of opportunities,
that is those <A NAME="a_Hlk35248048"></A>three opportunities he mentioned&mdash;clinical enhancements, business operations and
revenue enhancements are also spot on. Before diving into the specifics of how DeepHealth&rsquo;s team and technology will address
each of these issues, I&rsquo;d actually like to review a couple of commonly discussed concepts to help set the stage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let&rsquo;s start with an analogy that&rsquo;s
gotten a lot of attention, namely the phrase data is the new oil. In some ways, that&rsquo;s a very apt analogy, but I&rsquo;d
like to say that a better one is that data is the new tight oil or tight natural gas. Getting the value out of the source requires
a lot of work, perhaps not precisely analogous to fracking but still a very energy intensive, sophisticated and time-consuming
process. If we were to continue that analogy, DeepHealth would be like an oil extraction company and RadNet would be like the Permian
Basin, a vast resource with tremendous potential.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,255,255); border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: justify">RadNet, Inc. &ndash; Deep Health Artificial
Intelligence Call, March 13, 2020</P>


</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bringing these two together enables so
much opportunity. This analogy may be even more apt because it&rsquo;s clear that the two companies are such a good fit for each
other. From DeepHealth&rsquo;s perspective, it&rsquo;s far more efficient for us to be inside the sources of data that we need
to do with the AI, that we want to do, to seamlessly deal with collecting the data. Something that, of course, is made much easier
at RadNet, since you&rsquo;ve heard RadNet owns the IT infrastructure itself.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also both have instance access to friendly
and cooperative medical experts to ensure that our AI isn&rsquo;t developed in a vacuum. This is something that other imaging companies
struggle with from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From RadNet&rsquo;s perspective, having
what you might think of as the fracking company in the world show up and offer to help them realize the value of all this data
is also very exciting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bluntly put, I believe that the most valuable
assets that RadNet has are not currently listed on its balance sheet. The data and clinical scale that RadNet has is so tremendous
that the opportunity to unlock that value is just incredibly exciting. That&rsquo;s one concept I wanted to discuss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Another concept that is quite common in
AI is to say that AI is going to replace radiologists. Well, I&rsquo;m a radiologist myself and RadNet works with over 750 radiologists
directly, and I can tell you that there&rsquo;s never been a better time to be a radiologist. AI is not going to replace us. AI
is empowering us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We at DeepHealth and at RadNet expect that
our machine learning technologies will enable RadNet physicians, meaning our affiliated radiologists, to practice medicine at the
very top of their license. We at DeepHealth are building the AI to do the drudgery parts of the job, which will enable our physicians
to provide better quality care while also being more productive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">How are we going to do that? What are some
of the specifics? Well, let me open the hood a little bit on our technology and our team to help explore that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As you know, at the core of DeepHealth,
from the name you might guess, is deep learning. Deep learning is the name given to a relatively new way that lets computers learn
to do certain tasks. In our case, the breakthrough is that we can develop deep learning technologies to actually help physicians
do a better job of interpreting images.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deep learning consists of taking what is
called a model, which is really just a set of equations, linear algebra equations, and adjusting the coefficients and the variables
in those equations until the model produces the answers that you were hoping to see. The great thing is that this adjustment can
be done automatically by exposing the set of equations or the model to training examples. If you want your model to distinguish
pictures of dogs or pictures of cats, you could starts with a computer model consisting of lots of linear algebra equations, show
those equations thousands of pictures that you know are a bunch of dogs, and other thousands of pictures that you know are pictures
of cats, and you will end up with a model or a software system that does a pretty good job of distinguishing dogs from cats. In
fact, this is no longer so hard to do. Many companies around the world are using systems like this today for everything from software
for self-driving cars to facial recognition to designing drugs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">But, what if you wanted a model to distinguish
dogs from wolves? Or in our case, images that were mammograms that show something that might be cancer versus mammograms that show
something that actually is cancer. This is where the hard work comes in.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We at DeepHealth have built teams of people,
very talented people, to address this question, and they in turn have built tools to start to address this type of question. As
with wolves versus dogs, we have carefully identified examples of, on mammograms, breast cancer versus not breast cancer, not by
using the opinions of humans but by tracking down pathologic evidence for each example, each one of those mammograms. Our team
has specifically built software tools, methods and even patented approaches for adapting deep learning to the specific needs of
our medical imaging problems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the case of breast cancer because fortunately
only one of 200 women who undergo screening mammography actually have breast cancer, the key to getting lots of pictures of wolves
is to be sure that you can first collect lots and lots of pictures of dogs. That&rsquo;s why we at DeepHealth are so excited to
be part of RadNet. Because of the large volume of medical images that RadNet generates every year, we have the opportunity to build
precise, powerful tools that really do answer important medical clinical questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,255,255); border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: justify">RadNet, Inc. &ndash; Deep Health Artificial
Intelligence Call, March 13, 2020</P>


</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that backdrop, now let&rsquo;s turn
back to Dr. Berger&rsquo;s categories, so where AI can benefit patients, and specifically help RadNet do its job better.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">His first category, clinical accuracy and
productivity, is where the DeepHealth team has been focusing its efforts in its first four years. To illustrate the power of AI
and its opportunity for clinical benefit, I would like to briefly discuss a little bit more screening mammography.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Screening mammography clearly saves lives.
It&rsquo;s been studied in multiple countries multiple times over the past three decades, and since screening has been introduced,
breast cancer deaths have indeed declined. But that doesn&rsquo;t mean that screen mammography is a perfect tool. Reading mammograms,
I can tell you from personal experience, is a difficult task, and it&rsquo;s difficult even for full-time experts. Because breast
cancer is fortunately still quite rare&mdash;as I said earlier, only one out of 200 women who get a screening mammogram actually
have a breast cancer present on that mammogram&mdash;but the signs of cancer, those one in 200, can be quite subtle. It&rsquo;s
actually not a bad analogy to go back to the idea of trying to sort dogs from pictures of wolves; sometimes they can look very,
very similar. Because it&rsquo;s so rare, only one in 200, that means the other 199 women do not have the breast cancer. All in
all, this is very much like the proverbial task of finding a needle in a haystack, and this can be for us physicians both simultaneously
very tedious because so many are normal, yet very stressful because as an interpreter you know that there&rsquo;s a cancer somewhere
in those 200 women&rsquo;s cases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because this task is so difficult, in turn
that means not all doctors are equally good at it. The best radiologist might catch well over 90% of the cancers, but there are
some who appear to catch more like 60%. Recent technology improvements in the way we take those pictures has made the task even
more difficult. A new technology called digital press tomosynthesis, which RadNet is a pioneer and a leader in rolling out&mdash;it&rsquo;s
sometimes called 3D mammography&mdash;does do a better job of showing the cancer on the mammogram, but because it&rsquo;s 3D instead
of 2D, it converts 50 to 100 times as many images for us experts to review, making our job even more difficult.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This situation is exactly where AI should
be able to help. We at DeepHealth, our team, has created a database of thousands and thousands of verified examples of breast cancer
to build AI software to identify even subtle signs of cancer. We&rsquo;ve been testing this software now with RadNet for over a
year&mdash;or I guess nearly a year&mdash;and we&rsquo;ve learned that our software can find cancers that human physicians sometimes
overlook, sometimes as much as a year earlier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We&rsquo;re now working with RadNet&rsquo;s
expert physicians to determine not only how much better at interpreting mammograms the DeepHealth software could allow doctors
to be, but also to measure how much more efficient they could be if the software could help them prioritize their work.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That&rsquo;s that first example, clinical
accuracy and productivity. It&rsquo;s very clear that there&rsquo;s some exciting opportunities there, some really exciting low-hanging
fruit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Now, the second category that Dr. Berger
mentioned of business and operating efficiencies is where RadNet&rsquo;s earlier team, Nulogix, has been working already. While
the breakthroughs in image analysis capture a lot of attention in the press and media, etc., many of the same deep learning tools
can be applied to non-imaging data. They can have substantial impact.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One example that RadNet has in active testing
now is a tool that analyzes the dozens, if not hundreds of variables that play in how to best submit a reimbursement request to
an insurance company. This helps RadNet immediately because having a claim rejected by an insurer not only means a delay in past
cash collection but it also raises the risk of never being paid at all. Of course, another big bonus of these kinds of applications,
these business applications of AI is since they&rsquo;re not involved in direct medical care, they do not require FDA approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The third category, revenue enhancement,
is something that Dr. Berger has already alluded to. If AI can help us lower our costs at RadNet to do screening exam patients,
be those examinations mammograms or lung CT scans, which have been proven to save lives in smokers and former smokers, or save
prostate MRI, then we can offer these exams to large populations at patients at an affordable cost and actually improve millions
and millions of lives. It&rsquo;s that opportunity, the RadNet opportunity, that makes us so excited to join together with them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,255,255); border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: justify">RadNet, Inc. &ndash; Deep Health Artificial
Intelligence Call, March 13, 2020</P>


</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In closing, I would just like to return
to the idea that RadNet&rsquo;s best assets are not yet visible on its balance sheet. I&rsquo;ve had a chance to work closely with
the RadNet team over the past year and we and my whole team are convinced that not only is the raw material present in the data
but that the entire RadNet management team and clinical teams also understand the possibilities here. They are eager to work with
our highly talented scientists to unlock these assets. Doing this in a business setting is very exciting to us because it sharpens
our scientific focus onto the things that are sustainable and valuable to all patients and to all stakeholders. We are very motivated
to get going, and with that I will close my remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks very much for your attention and
I think we&rsquo;re going to turn it now to some questions. Is that right, Dr. Berger?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, Greg, thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All right, we will take your questions.
Please, Operator, give us the first questioner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, sir. If you would like to ask
a question at this time, please signal by pressing star, one on your telephone keypad. Please make sure that your mute function
is turned off to allow your signal to reach our equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once again everyone, that is star, one
at this time if you would like to ask a question. We&rsquo;ll pause for just a few moments to allow everybody the opportunity to
signal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One more time, that is star, one if you
would like to ask a question. We&rsquo;ll pause again for another moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Greg Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we&rsquo;re waiting for people to
come up with their questions, let me just jump in because I can repeat a few questions that I often get about deep learning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One is I&rsquo;d just like to circle back
to this question of will it replace radiologists, and are radiologists doomed? There&rsquo;s a famous meme going around about how
radiologists might be like Wiley Coyote that are already over the cliff.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That statement was made back in 2016 or
so. Here we are five years later or four years later and the job market for radiologists is fantastic. There&rsquo;s huge demand
for our specialty, and that&rsquo;s because so many people the value that imaging provides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RadNet, by being focused on imaging, really
does bring one of the most valuable technologies to patients and the opportunity for AI to speed that up and to make it more efficient
and to improve its quality, this is what radiologists really are excited about, this human element of actually speaking with a
woman to explain what&rsquo;s going on in her mammogram, discuss the procedure of a biopsy you might do. These things are never
going to go away. Computers are never going to actually consult with patients, at least I don&rsquo;t see that happening in my
lifetime.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It's really a symbiotic relationship where
the AI and the doctors work together to actually deliver things in a much smoother and a more efficient way.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;ll pause here and see if there&rsquo;s
any questions coming in.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It looks like we do have a question from
Mitra Ramgopal with Sidoti.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, hi. Good morning. Thanks for taking
the questions. First, I just wanted to get a sense in terms of what the details they are able to bring to the table that, for example,
Nulogix might not have been able to offer. As you combine the two entities, would you say you have the full range of capabilities
to be able to drive toward force efficiencies and lower the cost that you intend to, or do you need to invest even more in bringing
in some additional technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, Mitra. It&rsquo;s a multifaceted
question. Let me try to break it apart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First off, the team that we had in Nulogix,
while very competent, was limited to practically speaking four people and their primary function, as Dr. Sorensen had mentioned,
was looking at business efficiencies such as improving our reimbursement operations by reducing denials, getting a better sense
of the professions at the front door for co-pays and self-pay, etc. Their functions, while their capabilities might have been broad
were rather limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With the acquisition of the DeepHealth
team, their focus has been solely on clinical opportunities and, as Dr. Sorensen was describing, primarily in the field of mammography.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the past four years, they&rsquo;ve
been performing that task of bringing a product to market, which we hope to apply for FDA approval later this year and then be
able to start using it clinically and perhaps even in selling it commercially.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The development for the basics of the algorithms
are used to develop these clinical tools, particularly as Dr. Sorensen was saying, identifying the cats versus dogs, once you&rsquo;ve
set up those processes they are more easily adaptable to other opportunities where you might want to use the same basic logic and
strategy, and which is what we hope that a DeepHealth team will turn to either after or simultaneous with their work in mammography.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As I mentioned in my opening remarks, our
particular focus will be for prostate screening and then lung screening and colon screening, all of which between the cancers that
are identified for those four organs comprise about 80% of all the cancers diagnosed in the United States annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market opportunity for us to develop
these tools is not only very broad and extensive, but it&rsquo;s more important that the understanding of how we want to have these
tools is something similar to mammography become adopted by the medical communities so that patients can get these in an affordable
manner and one where they can self-refer if they have either the clinical background and risk assessment or just as part of screening,
for example like prostate cancer, can be done on a regular basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The need that RadNet or anybody would have
to attack this kind of a broad approach would require substantial resources and assets. Even if we go after the more strategic
initiatives that we&rsquo;d like RadNet to pursue because they lead not only to the clinical and accuracy of our radiologists,
they lead to revenue opportunities. These are still only a fraction of the opportunities inside artificial intelligence, and it&rsquo;s
quite likely because we have been working with other teams on artificial intelligence that come to us for both our data extraction
as well as clinical expertise, that we will be either partnering or collaborating with other teams so that we can further develop
in a more expeditious manner the benefits of artificial intelligence inside RadNet and for the community. I expect this to be a
broad approach. I think it&rsquo;s important that we had somebody of Dr. Sorensen&rsquo;s capability, both from a clinical standpoint,
a research standpoint and a business standpoint be able to lead what I see as a broad-based initiative on the part of the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It's also quite possible that we&rsquo;ll
be working with some of our manufacturers, the OEMs equipment that we buy, given the resources that we have and tools, both in
terms of the amount of equipment that we might have out there and the ability to implement a wide range of delivery of these services,
as well as having expertise in running the business side of (inaudible) that most of the equipment manufacturers lack.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I see the resources both coming from an
expansion of the combination of the DeepHealth and Nulogix teams that Dr. Sorensen will oversee, as well as bringing in other relationships
with business entities, whether they be manufacturers or people that are just focused on other parts of the AI opportunities as
part of an overall strategy for the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Great. Thanks for the color on that. I
was also wondering if maybe you could give us a sense in terms of how does the FDA approval work for AI and your sense in terms
of getting your product to market, the kind of timeframe we should be looking at.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Greg Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure, great question I&rsquo;ll take that.
This is Greg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The FDA has asserted jurisdiction over
medical imaging artificial intelligence products. They consider them medical devices. In past decades they considered them Class
3 devices or certain risk categories, but in the past year or so they have reclassified most AI tools, like the ones we&rsquo;re
developing, to be Class 2 devices that will require 510(k) clearance before they can be used in interstate commerce.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We at DeepHealth have been spending a substantial
amount of time in talking with folks at the FDA. We&rsquo;ve met repeatedly with them. We&rsquo;ve built a good relationship of
trust and of scientific integrity, and we believe that will be an ongoing part of our strategy where we will continue to work closely
with FDA about the products we want to bring to market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The typical 510(k) process, as you know,
these days, well, it does kind of continue to evolve because AI is such a new field, but in general the FDA requests that you have
what they call a presubmission meeting with them. You kind of go in and explain what you&rsquo;re thinking about doing. They give
you some feedback. That takes a few months. Then you go off and do the work that you&rsquo;ve essentially laid out of what you
expect to do. That can usually take a few months. Then you submit the material to the FDA and they get a few months to actually
review things.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All in all, once you&rsquo;re kind of pretty
close to done with your technology and ready to start the regulatory process, that can be about a year, sometimes a little longer.
It depends on how good your science is going into the FDA first.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To your specific question about RadNet
tools, we will be getting FDA clearance for those AI technologies that the FDA has guided us that require FDA clearance and we
expect that will be a pipeline of things over the years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In your earlier question, just to echo
what Dr. Berger said earlier, there&rsquo;s so many opportunities in AI and radiology, and RadNet has such a broad portfolio. It&rsquo;s
not like we&rsquo;re a single imaging modality business, that for some things we&rsquo;re going to build internally at DeepHealth,
some things it will just make more sense businesswise for us to buy, if you will, or to go outside our partner with external parties.
We&rsquo;ll be looking at that closely as we move ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It's definitely not a not-invented here
syndrome here. We&rsquo;re very open, so the best technologies wherever we can find them to help RadNet meet its mission and to
help our patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That&rsquo;s great. Just to follow-up a
little on that, obviously the focus has been on mammography. How easy or how quickly do you think you will be able to use these
technologies on some of the other modalities?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Greg Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some of the modalities have tools commercially
available already today. RadNet has been evaluating a number of them commercially, even as we speak. The real question I think
from an investor point of view and from an owner point of view is how valuable are those? That&rsquo;s really the process that
I think we&rsquo;ll be doing over the next quarter or two is trying to figure out which of these technologies can really make an
impact for our shareholders and for our operations, versus the kind of more nice to have but not necessarily meaningful? I expect
that over the course of 2020 we will identify some things that really will have a meaningful impact.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Now, in medicine things take a long time,
practices and habits take a while to change because there&rsquo;s so many people involved, so I wouldn&rsquo;t want to overpromise
or say we&rsquo;re going to see things turn on a dime, but the opportunities to identify those, RadNet is really well situated
for because we have such broad operations, we can kind of distribute different opportunities to different teams and in parallel
identify, I don&rsquo;t know, 5 or 10 different things all kind of almost simultaneously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think we&rsquo;re as well situated, perhaps
better situation than most entities out there to address the AI opportunities at scale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let me interject something for a moment,
Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Greg, can you give some perspective, at
least as it relates to mammography AI where DeepHealth is in the current process of filing for FDA approval?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Greg Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. Specifically with our product, we
met with the FDA last November for what&rsquo;s called this presubmission meeting. Had a very productive, positive experience there.
Came out with some very clear guidance from the FDA about how to proceed. We will be meeting with them again next month to get
final approval for our execution plan, and basically the way that works is you come up with essentially an agreement with the FDA,
a handshake agreement equivalent, where they essentially say if you execute the scientific process that you are proposing to us
and it turns out with the scientifically proven answers you think it will, then that will support the kind of claims that you&rsquo;re
looking for. In our case, we&rsquo;re looking at DeepHealth and RadNet not just to have a claim that says we can do a little bit
better at maybe interpreting mammograms, but we&rsquo;re very focused on being able to demonstrate to the FDA&rsquo;s satisfaction
and our own satisfaction that the AI actually makes a meaningful difference in women&rsquo;s lives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We don&rsquo;t yet have clearance of what
that will actually look like so I can&rsquo;t give you a specific quote of what the FDA will agree to. The scientific thing I can
tell you, we&rsquo;re interested in things like something like a physician who interprets a mammogram using DeepHealth software
would find cancer earlier than if they interpreted a mammogram without DeepHealth software, that kind of thing. Our data suggests
that we&rsquo;ll be able to do that. We think that&rsquo;s a substantially unique differentiator in the marketplace and that more
importantly it will be something that our referring physicians see as very valuable for their women, their female patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That&rsquo;s the kind of direction we want
to go, not just the dollar operational efficiencies, but meaningful improvements in women&rsquo;s and men&rsquo;s lives. We think
that&rsquo;s particularly valuable in the RadNet setting because of something we haven&rsquo;t really talked about on this call
but I know came up in yesterday&rsquo;s call, and that was RadNet is unique in that it has capitated lives, or relatively unique.
Not many radiology providers can take on capitation, and that opens a whole series of value propositions for artificial intelligence
that are going to be possible and even very meaningful, that when you&rsquo;re at sort of an outside the tent or not so closely
linked, just become much harder to do or monetize. There&rsquo;s a bunch of things we&rsquo;re going to be able to do together
by working hand-in-glove and by DeepHealth being part of RadNet and RadNet having its own DeepHealth, if you will, that would just
other just be much harder to do from a business perspective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Inaudible).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(Inaudible) a couple of things before perhaps
if you had another question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First of all, to put it better in perspective,
even though only one out of every 200 women who we do screening mammography on ultimately get diagnosed with breast cancer, in
the general population one out of every eight women will get some form of breast cancer in their lifetime. You are talking about
a very substantial problem and as Dr. Sorensen suggested, even though there has been great strides in diagnosing breast cancer
earlier, it hasn&rsquo;t necessarily reduced the number of breast cancers; it&rsquo;s simply allowing us to diagnose it earlier
and with the use of artificial intelligence and other technologies such as 3D tomography, we should be able to diagnose these earlier
and ultimately reduce morbidity and lower the cost to the system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think it&rsquo;s important for all of
us to understand that this is about scale and that goes to the heart of RadNet&rsquo;s decision to become fully invested in artificial
intelligence. We are on a trajectory to do about 2 million mammograms a year and so on an annual basis that would represent close
to 5% of all mammography performed in the United States and that&rsquo;s done in ostensibly the five major markets that we&rsquo;re
in.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you wanted to take technology such as
what DeepHealth is on the brink of getting FDA approval from, and then purchase that, even if they add $1 or $2 per read, per scan,
it would cost the company $2 million to $4 million and be an ongoing cost that we would continue to bear regardless of how many
mammograms are ultimately done inside the RadNet organization, and we&rsquo;d only be able to do with that kind of expenditure
really one product or have one product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mammography is unique in what we do in
that every mammogram that we perform will need to be subjected to artificial intelligence. This isn&rsquo;t a matter of saying
we only use artificial intelligence on the (inaudible) that you ultimately diagnose to have breast cancer; it&rsquo;s a tool that
will help more accurately and earlier identify those cases so every mammogram we do will need to be subjected to artificial intelligence,
both to determine normal from not normal and then essentially be another pair of eyes to help the radiologist read these more accurately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The same logic could apply and should apply
to, for example, prostate cancer. Every man, should they live long enough, is likely to get prostate cancer. The question in some
of the medical communities is often what do you do for the testing and what then do you do for treatment given that prostate cancer
and many of the prostate cancers will not necessarily be something which ultimately leads to somebody&rsquo;s demise, but becomes
a very substantial cost to the system to treat. We firmly believe&mdash;and we&rsquo;ve done some initial work with this&mdash;that
we can develop a tool that will make prostate MRI screening as easy and as affordable as mammographist training. We&rsquo;ll substantially
reduce the cost of the diagnosis and will allow I think the payors to make this every bit as accessible to their membership as
mammography is now to women.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I want to put that in perspective because
that becomes another tool that we believe will be suggested to every prostate MR that we do. We just hope to do them earlier, diagnose
them faster and more accurately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The other comment I would want to make&mdash;this
is really looking down the road a piece&mdash;is that when we do a mammogram and we do an MRI, particularly of the prostate, there
is a lot of information on those scans that are simply discarded because they&rsquo;re either not the reason why the test is ordered
or they&rsquo;re just not practically capably of doing. I saw recently an article about a team out of Stanford that won an award
for taking knee scans and subjecting them to artificial intelligence and then being able to determine risk assessment for cardiovascular
disease in all those patients that had knee MRIs regardless of whether the knee itself was determined to be normal or abnormal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Essentially, that kind of information is
available on every scan or procedure that is done in imaging and that data, which is another part of the assets, if you will, that
any radiology company or provider owns, is something that I think can yield an enormous amount of valuable information, particularly
from mammography or prostate if they were to do that on a swing basis for the population, would essentially be additional information
that wouldn&rsquo;t cost anything more to develop than giving the opportunity for artificial intelligence (inaudible) particular
perspective that we&rsquo;re trying to achieve with that diagnostic information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The perspective of what we&rsquo;re talking
about in artificial intelligence is really not just that one tool but potentially looking at the spectrum of the impact artificial
intelligence can have overall in the delivery of healthcare, particularly as it&rsquo;s representative of the radiology diagnostic
imaging field.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m sorry, Mitra, if you had another
comment or question you&rsquo;d like to ask us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No, that is great. Actually, the final
question&mdash;and again, this is more down the road&mdash;would the reimbursement be necessarily any different if AI is used versus
non-AI?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, that&rsquo;s probably again going
back to my analogy of the $64,000 question, although that&rsquo;s from a number of years ago, that TV series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">My guess is the answer to that may be no.
I don&rsquo;t know if anybody is going to pay any more because you&rsquo;re doing it. It&rsquo;s more likely to be that you would
do more and see more of those patients because you&rsquo;re doing it and providing a value added to the system that will make you
a better provider and a better partner in dealing with the overall health of that patient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Now, I could be wrong but if you look at
what&rsquo;s happened over the years in imaging, as new technology has been advanced, nobody is running out there and generally
paying us more money. The one exception to that is perhaps at this time 3D mammography which does have an additional code that
you get reimbursed on above and beyond 2D mammography, but even the number of dollars that we get paid for that are not necessarily
reflective of the additional investment that has to be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, 3D tomography for the mammography
procedures is now the state of the art and most people will be expecting you to perform that exam, and if you don&rsquo;t, you&rsquo;re
at a competitive disadvantage. I expect the same type of thing to be embraced by the payors and others that will have artificial
intelligence as a requirement that if you don&rsquo;t provide it you actually may get less money, and that indeed has some historical
precedent&mdash;thank you, Greg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Greg Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It becomes the new normal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, and I&rsquo;ll give you the example
for that what that when the industry moved to digital radiology and it was required for reimbursement by CMS, they wouldn&rsquo;t
pay you more if you did it; they paid you less if you didn&rsquo;t do it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Again, perhaps I&rsquo;m being a little
overly dramatic when I use the term existential necessity, but I think we have to work from a historical standpoint and be rather
sanguine about what&rsquo;s going to happen on the reimbursement side.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We all tend to live in this world, by the
way, of still everything is on a fee-for-service basis, but the industry is moving more to population health, alternative reimbursement
models, risk taking, getting paid by better outcomes, if you will, and artificial intelligence will be a critical part of that
opportunity moving forward.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Greg Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If I could just echo one thing, kind of
that I want to bring out. The scale of RadNet enables us to have the potential to develop these AI tools. Dr. Berger mentioned
that we&rsquo;re going to do we think this year 2 million mammograms. That&rsquo;s as many as the entire United Kingdom will do
next year. RadNet can collect data, analyze data, get all those pictures of dogs or wolves or whatever analogy you want to use
to answer the most critical and valuable questions at a scale very few other organizations can even contemplate. We have our own
internal AI system&mdash;I&rsquo;m sorry, IT system, so all the data collection gets streamlined. We have a lot of alignment of
interests. Just the opportunity to catapult ahead and really bring these technologies to patients and to make business impact faster,
just really a remarkable opportunity that we both saw and we&rsquo;re just super excited about.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I really appreciate the color and thanks
for taking the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have no further questions at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Great. All right, well, thank you all for
joining us today and please stay tuned for exciting developments that RadNet hopes to be able to deliver this year and bring better
medicine, which is good business, to the marketplace. Thank you all for your time this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Greg Sorensen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Bye.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That does conclude today&rsquo;s conference.
We thank everyone again for their participation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
